Here's Why We're Not Too Worried About PharmAust's (ASX:PAA) Cash Burn Situation
Apr 09
Australian (ASX) Pharma Industry Analysis
UpdatedApr 24, 2024
DataAggregated Company Financials
Companies30
- 7D-1.7%
- 3M-4.1%
- 1Y31.3%
- YTDn/a
Over the last 7 days, the Pharma industry has dropped 4.8%, driven by a pullback from Clarity Pharmaceuticals of 7.0%. Over the past 12 months, the industry was up 31%. Earnings are forecast to grow by 28% annually.
Industry Valuation and Performance
Has the Australian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 24 Apr 2024 | AU$5.5b | AU$1.2b | -AU$374,923,684.00 | 13.5x | -14.7x | 4.5x |
| Fri, 22 Mar 2024 | AU$5.7b | AU$1.2b | -AU$374,923,684.00 | 14.7x | -15.3x | 4.7x |
| Sun, 18 Feb 2024 | AU$5.3b | AU$892.3m | -AU$534,729,129.00 | 20.4x | -9.9x | 5.9x |
| Tue, 16 Jan 2024 | AU$5.7b | AU$896.3m | -AU$589,604,392.00 | 21.4x | -9.7x | 6.4x |
| Thu, 14 Dec 2023 | AU$4.5b | AU$896.3m | -AU$589,604,392.00 | 16.6x | -7.7x | 5.1x |
| Sat, 11 Nov 2023 | AU$4.0b | AU$893.0m | -AU$595,020,018.00 | 18.1x | -6.7x | 4.5x |
| Mon, 09 Oct 2023 | AU$3.6b | AU$900.3m | -AU$587,952,018.00 | 19x | -6.1x | 4x |
| Wed, 06 Sep 2023 | AU$3.7b | AU$900.3m | -AU$587,952,018.00 | 19.6x | -6.3x | 4.1x |
| Fri, 04 Aug 2023 | AU$4.1b | AU$999.0m | -AU$624,794,303.00 | 21.5x | -6.5x | 4.1x |
| Sun, 02 Jul 2023 | AU$4.0b | AU$999.0m | -AU$624,794,303.00 | 22.7x | -6.3x | 4x |
| Tue, 30 May 2023 | AU$4.0b | AU$993.2m | -AU$640,306,659.00 | 18.5x | -6.3x | 4.1x |
| Thu, 27 Apr 2023 | AU$4.2b | AU$993.2m | -AU$641,969,868.00 | 18.5x | -6.6x | 4.3x |
| Sat, 25 Mar 2023 | AU$4.0b | AU$995.9m | -AU$648,651,745.00 | 18.2x | -6.2x | 4.1x |
| Mon, 20 Feb 2023 | AU$3.6b | AU$980.5m | -AU$583,404,566.00 | 16.6x | -6.2x | 3.7x |
| Wed, 18 Jan 2023 | AU$11.6b | AU$948.3m | -AU$544,428,006.00 | 12.9x | -21.3x | 12.2x |
| Fri, 16 Dec 2022 | AU$3.9b | AU$948.3m | -AU$544,428,006.00 | 13.5x | -7.2x | 4.1x |
| Sun, 13 Nov 2022 | AU$4.3b | AU$948.3m | -AU$544,428,005.00 | 12.7x | -8x | 4.6x |
| Tue, 11 Oct 2022 | AU$4.2b | AU$946.2m | -AU$548,400,005.00 | 12.4x | -7.7x | 4.5x |
| Thu, 08 Sep 2022 | AU$4.2b | AU$943.2m | -AU$537,548,829.00 | 12.5x | -7.7x | 4.4x |
| Sat, 06 Aug 2022 | AU$3.9b | AU$819.9m | -AU$339,669,589.00 | 15.6x | -11.6x | 4.8x |
| Mon, 04 Jul 2022 | AU$3.3b | AU$818.2m | -AU$353,932,589.00 | 12.9x | -9.3x | 4x |
| Wed, 01 Jun 2022 | AU$4.0b | AU$818.2m | -AU$353,932,589.00 | 15x | -11.2x | 4.8x |
| Fri, 29 Apr 2022 | AU$4.0b | AU$800.9m | -AU$348,637,558.00 | 15.6x | -11.5x | 5x |
| Sun, 27 Mar 2022 | AU$4.3b | AU$799.2m | -AU$341,805,125.00 | 18x | -12.7x | 5.4x |
| Tue, 22 Feb 2022 | AU$4.5b | AU$749.9m | -AU$461,485,291.00 | 19.9x | -9.8x | 6.1x |
| Thu, 20 Jan 2022 | AU$4.9b | AU$758.4m | -AU$450,516,414.00 | 21.3x | -10.9x | 6.5x |
| Sat, 18 Dec 2021 | AU$4.8b | AU$758.4m | -AU$450,516,414.00 | 23.7x | -10.5x | 6.3x |
| Mon, 15 Nov 2021 | AU$4.9b | AU$758.4m | -AU$447,307,205.00 | 24x | -11x | 6.5x |
| Wed, 13 Oct 2021 | AU$4.7b | AU$753.7m | -AU$446,965,453.00 | 23.5x | -10.4x | 6.2x |
| Fri, 10 Sep 2021 | AU$4.7b | AU$753.9m | -AU$445,060,581.00 | 21.9x | -10.6x | 6.3x |
| Sun, 08 Aug 2021 | AU$4.1b | AU$752.8m | -AU$442,004,016.00 | 20.8x | -9.3x | 5.5x |
| Sat, 01 May 2021 | AU$4.8b | AU$758.7m | -AU$449,177,839.00 | 12.3x | -10.6x | 6.3x |
Price to Earnings Ratio
-10.6x
Current Industry PE
- Investors are relatively neutral on the Australian Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 5.0x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
- Revenues for these companies have grown 17% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Comparison
How does Australian Pharma compare with similar industries?
| AU Market | 0.89% | |
| Healthcare | 2.06% | |
| Pharma | -1.65% | |
| Pharma | -1.65% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| MYX Mayne Pharma Group | AU$7.10 | 6.6% +AU$35.7m | 74.4% | PS1.8x | |
| RCE Recce Pharmaceuticals | AU$0.69 | 29.2% +AU$31.6m | 7.9% | PS20.7x | |
| AGN Argenica Therapeutics | AU$0.56 | -5.1% AU$9.9m | 25.8% | PS25.2x | |
| IVX Invion | AU$0.006 | 20.0% +AU$6.4m | -14.3% | PS8.8x | |
| SPL Starpharma Holdings | AU$0.14 | 3.8% +AU$2.1m | -73.0% | PS5.3x |
